| 📰 Ministry of Health, Labour and Welfare Press Release

Cabinet Decision on “Policies for Promoting Foundational Manufacturing Technologies for Reiwa 7” (Monozukuri White Paper)

SUMMARY

According to a press release from the Ministry of Health, Labour and Welfare, the "Cabinet Decision on "Policies for Promoting Foundational Manufacturing Technologies for Reiwa 7" (Monozukuri White Paper)" has been announced. This information serves as a reference for management decisions in the healthcare sector, including hospitals, clinics, and medical corporations, reflecting the latest industry trends.

📝 EDITOR'S NOTE — A Medical M&A Perspective

Trends in the medical industry directly impact the succession and M&A strategies of hospitals, clinics, and medical corporations. Changes in the complex management environment, such as revisions to medical fees, lack of successors, staffing shortages, burden of capital investment, and progress in regional medical plans, are forcing medical institutions to make new management decisions.

As an option for successor issues and changes in the management environment,Third-Party Succession M&Ais increasing in importance year by year. Choosing succession over closure or廃業 (business dissolution) allows for the simultaneous achievement of securing a transfer price, maintaining staff employment, ensuring continuity of patient care, and preserving regional medical services. The framework of M&A support institutions certified by the Small and Medium Enterprise Agency has also been established, and advisory services specializing in the unique licensing, tax, and labor issues of the medical industry have become widespread.

For medical institutions, accurately grasping industry trends and seeking early consultation with experts are key to attracting the best options for management decisions. As an M&A advisory firm specializing in the medical industry, we support medical institutions with free consultations and success-fee-based services.

News Highlights

Points for Medical M&A and Business Succession Gleaned from This News

  • Options for Successor Issues: The value of choosing third-party succession over clinic closure or business dissolution.
  • Value of Early Consideration: Preparation by the chairman/director starting around age 60, with a 5-10 year timeframe.
  • Engagement of Specialized Advisors: Utilization of support organizations specializing in the medical industry.

Related Sponsors

📌 Source (Primary Information)

Cabinet Decision on “Policies for Promoting Foundational Manufacturing Technologies for Reiwa 7” (Monozukuri White Paper)

Source: Ministry of Health, Labour and Welfare Press Releases

Please see the original article for details

Regarding trends in medical institutions like this case,

we provide a detailed explanation of the 'Medical Succession Guide'

Read the Complete Guide →

📚 Related Medical Succession Columns

For medical succession consultations, contact M&A Medical

Strict confidentiality, free initial consultation, success-based fee.

Apply for a Free Consultation